Fujian Wanchen Biotechnology Group Balance Sheet Health
Financial Health criteria checks 4/6
Fujian Wanchen Biotechnology Group has a total shareholder equity of CN¥998.4M and total debt of CN¥957.6M, which brings its debt-to-equity ratio to 95.9%. Its total assets and total liabilities are CN¥4.4B and CN¥3.4B respectively. Fujian Wanchen Biotechnology Group's EBIT is CN¥16.1M making its interest coverage ratio 0.5. It has cash and short-term investments of CN¥1.7B.
Key information
95.9%
Debt to equity ratio
CN¥957.63m
Debt
Interest coverage ratio | 0.5x |
Cash | CN¥1.71b |
Equity | CN¥998.40m |
Total liabilities | CN¥3.42b |
Total assets | CN¥4.42b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300972's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥2.8B).
Long Term Liabilities: 300972's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥591.5M).
Debt to Equity History and Analysis
Debt Level: 300972 has more cash than its total debt.
Reducing Debt: 300972's debt to equity ratio has increased from 87.1% to 95.9% over the past 5 years.
Debt Coverage: 300972's debt is well covered by operating cash flow (132.6%).
Interest Coverage: 300972's interest payments on its debt are not well covered by EBIT (0.5x coverage).